. O2–06–03: ACU-193: A candidate therapeutic antibody that selectively targets soluble beta-amyloid oligomers. Alzheimer's & Dementia, July 2013 Alzheimer's & Dementia

Recommends

Please login to recommend the paper.

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.

This paper appears in the following:

Therapeutics

  1. Sabirnetug